Judge Calabrese Issues Case Management Order #3 in Suboxone Tooth Decay MDL
Case Management Order #3 (CMO #3) allows for direct filing of cases into the Suboxone MDL, aiming to streamline the legal process and enhance judicial efficiency. Plaintiffs alleging dental injuries from sublingual Suboxone may file their lawsuits in the Northern District of Ohio as member cases.
Focus on Complete Tooth Loss
The plaintiffs steering committee anticipates that cases in the MDL will focus primarily on instances of complete tooth loss, with many current clients having experienced at least one tooth extraction or loss after extended use of Suboxone sublingual strips.
Statute of Limitations Reminder
With the statute of limitations expiring in June for states with a two-year statute on product liability claims, the deadline for accepting claims from individuals in these states is April 1, 2024. This deadline is crucial for those seeking legal action related to Suboxone tooth decay.
Anticipated Increase in Lawsuits
Following changes to the warning label of sublingual Suboxone in June 2022, a surge in Suboxone lawsuits is expected over the next sixty days, as individuals affected by dental injuries seek legal recourse through the MDL.
Expected Surge in Advertising
After the Mass Torts Made Perfect conference in early April, an increase in advertising for Suboxone tooth decay claims is anticipated. Vendors are likely to launch campaigns due to the perceived strength of the scientific evidence and the market cap of Reckitt Benckiser, the parent company of Indivior.
